Delcath Systems (NASDAQ:DCTH – Get Free Report) is set to post its quarterly earnings results after the market closes on Monday, August 5th. Analysts expect Delcath Systems to post earnings of ($0.34) per share for the quarter. Parties that wish to listen to the company’s conference call can do so using this link.
Delcath Systems (NASDAQ:DCTH – Get Free Report) last issued its earnings results on Tuesday, May 14th. The company reported ($0.43) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.43). The company had revenue of $3.14 million during the quarter, compared to analyst estimates of $3.70 million. Delcath Systems had a negative return on equity of 290.07% and a negative net margin of 1,080.72%. On average, analysts expect Delcath Systems to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.
Delcath Systems Price Performance
Shares of DCTH stock opened at $8.12 on Friday. The firm has a market capitalization of $225.62 million, a price-to-earnings ratio of -3.06 and a beta of 0.64. The business has a fifty day moving average of $7.80 and a 200 day moving average of $5.94. Delcath Systems has a 1 year low of $2.25 and a 1 year high of $9.18.
Analyst Upgrades and Downgrades
Check Out Our Latest Stock Report on DCTH
Delcath Systems Company Profile
Delcath Systems, Inc, an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.
Featured Stories
- Five stocks we like better than Delcath Systems
- What Are Dividend Champions? How to Invest in the Champions
- Hims & Hers Stock Falls on DexCom Fears: Analysts Predict Rally
- What Investors Need to Know About Upcoming IPOs
- Snap’s Stock Plummets on Q2 Revenue Guidance Shortfall
- Stock Sentiment Analysis: How it Works
- Intel Loses a Quarter of Its Value After Horrible Earnings Report
Receive News & Ratings for Delcath Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Delcath Systems and related companies with MarketBeat.com's FREE daily email newsletter.